On Apr. 29, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine announced that they had begun testing the drug hydroxychloroquine for the treatment of COVID-19, as part of a nationwide trial sponsored by the National Heart, Lung, and Blood Institute.